These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12139456

  • 21. Gadolinium DOTA chelates featuring alkyne groups directly grafted on the tetraaza macrocyclic ring: synthesis, relaxation properties, "click" reaction, and high-relaxivity micelles.
    Vanasschen C, Bouslimani N, Thonon D, Desreux JF.
    Inorg Chem; 2011 Sep 19; 50(18):8946-58. PubMed ID: 21859074
    [Abstract] [Full Text] [Related]

  • 22. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
    Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF.
    J Nucl Med; 1990 Apr 19; 31(4):473-9. PubMed ID: 2324823
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
    Chong HS, Song HA, Ma X, Milenic DE, Brady ED, Lim S, Lee H, Baidoo K, Cheng D, Brechbiel MW.
    Bioconjug Chem; 2008 Jul 19; 19(7):1439-47. PubMed ID: 18564868
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.
    Chong HS, Sun X, Chen Y, Sin I, Kang CS, Lewis MR, Liu D, Ruthengael VC, Zhong Y, Wu N, Song HA.
    Bioorg Med Chem; 2015 Mar 01; 23(5):1169-78. PubMed ID: 25648683
    [Abstract] [Full Text] [Related]

  • 27. Pyclen Tri-n-butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to (90)Y Radiolabeling.
    Le Fur M, Beyler M, Lepareur N, Fougère O, Platas-Iglesias C, Rousseaux O, Tripier R.
    Inorg Chem; 2016 Aug 15; 55(16):8003-12. PubMed ID: 27486673
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis of 2-(p-thiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid: application of the 4-methoxy-2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines.
    McMurry TJ, Brechbiel M, Wu C, Gansow OA.
    Bioconjug Chem; 1993 Aug 15; 4(3):236-45. PubMed ID: 8324015
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Kinetic stability studies on yttrium(III)-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid by free-ion selective radiotracer extraction.
    Jurkin D, Gildehaus FJ, Wierczinski B.
    Anal Chem; 2007 Dec 15; 79(24):9420-6. PubMed ID: 18001130
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
    Wei L, Butcher C, Miao Y, Gallazzi F, Quinn TP, Welch MJ, Lewis JS.
    J Nucl Med; 2007 Jan 15; 48(1):64-72. PubMed ID: 17204700
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
    Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF.
    Clin Cancer Res; 2005 Nov 15; 11(22):8180-5. PubMed ID: 16299250
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cyclen-based Gd3+ complexes as MRI contrast agents: Relaxivity enhancement and ligand design.
    Rashid HU, Martines MAU, Jorge J, de Moraes PM, Umar MN, Khan K, Rehman HU.
    Bioorg Med Chem; 2016 Nov 15; 24(22):5663-5684. PubMed ID: 27729196
    [Abstract] [Full Text] [Related]

  • 38. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
    Lewis MR, Shively JE.
    Bioconjug Chem; 1998 Nov 15; 9(1):72-86. PubMed ID: 9460549
    [Abstract] [Full Text] [Related]

  • 39. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of 68Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model.
    Guleria M, Das T, Amirdhanayagam J, Sarma HD, Dash A.
    Cancer Biother Radiopharm; 2018 Feb 15; 33(1):8-16. PubMed ID: 29373046
    [Abstract] [Full Text] [Related]

  • 40. H2CHXdedpa and H4CHXoctapa-chiral acyclic chelating ligands for (67/68)Ga and (111)In radiopharmaceuticals.
    Ramogida CF, Cawthray JF, Boros E, Ferreira CL, Patrick BO, Adam MJ, Orvig C.
    Inorg Chem; 2015 Feb 16; 54(4):2017-31. PubMed ID: 25621728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.